Schwarz Investment Partners, Inc.’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
Other funds holding CCCC
LCM
Schwarz Investment Partners, Inc.'s CCCC Position: Q3 2026 in Review
Schwarz Investment Partners, Inc. opened a new position in C4 Therapeutics (CCCC) in Q3 2026: 1,000 shares worth $2.95K. The stake represents ﹤0.01% of the portfolio and ranks #255 among its holdings.
151 funds tracked by Wall St. Rank hold CCCC as of Q3 2026.
- Schwarz Investment Partners, Inc. held 1,000 shares of C4 Therapeutics worth $2.95K as of Q3 2026.
- C4 Therapeutics was a new Schwarz Investment Partners, Inc. position in Q3 2026.
- C4 Therapeutics made up ﹤0.01% of Schwarz Investment Partners, Inc.'s portfolio in Q3 2026, its #255 holding.
- 151 funds tracked by Wall St. Rank held C4 Therapeutics as of Q3 2026.
Based on Schwarz Investment Partners, Inc.'s 13F filing for Q3 2026, filed 17 Nov 2026.